Our histological, histochemical, and flow cytometric analyses all support the notion that dexamethasone is effective in reducing eosinophilia without impacting the numbers of CCR2+ monocyte accumulation in the lung, resulting in beneficial effects on the trajectory of the disease. Here, CCR2 is linked to Increased total eosinophil count.